156 related articles for article (PubMed ID: 10229624)
1. Comparative molecular field analysis of hydantoin binding to the neuronal voltage-dependent sodium channel.
Brown ML; Zha CC; Van Dyke CC; Brown GB; Brouillette WJ
J Med Chem; 1999 May; 42(9):1537-45. PubMed ID: 10229624
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and structure-activity relationship studies for hydantoins and analogues as voltage-gated sodium channel ligands.
Zha C; Brown GB; Brouillette WJ
J Med Chem; 2004 Dec; 47(26):6519-28. PubMed ID: 15588087
[TBL] [Abstract][Full Text] [Related]
3. Effects of log P and phenyl ring conformation on the binding of 5-phenylhydantoins to the voltage-dependent sodium channel.
Brown ML; Brown GB; Brouillette WJ
J Med Chem; 1997 Feb; 40(4):602-7. PubMed ID: 9046351
[TBL] [Abstract][Full Text] [Related]
4. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase.
Holder S; Lilly M; Brown ML
Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507
[TBL] [Abstract][Full Text] [Related]
5. Bicyclic hydantoins with a bridgehead nitrogen. Comparison of anticonvulsant activities with binding to the neuronal voltage-dependent sodium channel.
Brouillette WJ; Jestkov VP; Brown ML; Akhtar MS; DeLorey TM; Brown GB
J Med Chem; 1994 Sep; 37(20):3289-93. PubMed ID: 7932556
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and pharmacological evaluation of conformationally constrained analogues of N,N'-diaryl- and N-aryl-N-aralkylguanidines as potent inhibitors of neuronal Na+ channels.
Maillard MC; Perlman ME; Amitay O; Baxter D; Berlove D; Connaughton S; Fischer JB; Guo JQ; Hu LY; McBurney RN; Nagy PI; Subbarao K; Yost EA; Zhang L; Durant GJ
J Med Chem; 1998 Jul; 41(16):3048-61. PubMed ID: 9685245
[TBL] [Abstract][Full Text] [Related]
7. Comparison of estrogen receptor alpha and beta subtypes based on comparative molecular field analysis (CoMFA).
Xing L; Welsh WJ; Tong W; Perkins R; Sheehan DM
SAR QSAR Environ Res; 1999; 10(2-3):215-37. PubMed ID: 10491851
[TBL] [Abstract][Full Text] [Related]
8. 3D-QSAR studies for the binding affinity toward (R, S)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionic acid receptor.
Sharma RN; Thakar H; Vasu KK; Chaturvedi SC
Acta Pharm; 2008 Sep; 58(3):335-45. PubMed ID: 19103570
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional quantitative structure-activity relationship study of nonsteroidal estrogen receptor ligands using the comparative molecular field analysis/cross-validated r2-guided region selection approach.
Sadler BR; Cho SJ; Ishaq KS; Chae K; Korach KS
J Med Chem; 1998 Jun; 41(13):2261-7. PubMed ID: 9632359
[TBL] [Abstract][Full Text] [Related]
10. QSAR study of a large set of 3-pyridyl ethers as ligands of the alpha4beta2 nicotinic acetylcholine receptor.
Zhang H; Li H; Ma Q
J Mol Graph Model; 2007 Jul; 26(1):226-35. PubMed ID: 17208024
[TBL] [Abstract][Full Text] [Related]
11. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
Hou T; Zhu L; Chen L; Xu X
J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
[TBL] [Abstract][Full Text] [Related]
12. Ligand-based design and synthesis of novel sodium channel blockers from a combined phenytoin-lidocaine pharmacophore.
Wang Y; Jones PJ; Batts TW; Landry V; Patel MK; Brown ML
Bioorg Med Chem; 2009 Oct; 17(19):7064-72. PubMed ID: 19346132
[TBL] [Abstract][Full Text] [Related]
13. Sodium channel binding and anticonvulsant activities of hydantoins containing conformationally constrained 5-phenyl substituents.
Brouillette WJ; Brown GB; DeLorey TM; Liang G
J Pharm Sci; 1990 Oct; 79(10):871-4. PubMed ID: 2177789
[TBL] [Abstract][Full Text] [Related]
14. CoMFA study of piperidine analogues of cocaine at the dopamine transporter: exploring the binding mode of the 3 alpha-substituent of the piperidine ring using pharmacophore-based flexible alignment.
Yuan H; Kozikowski AP; Petukhov PA
J Med Chem; 2004 Dec; 47(25):6137-43. PubMed ID: 15566285
[TBL] [Abstract][Full Text] [Related]
15. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
[TBL] [Abstract][Full Text] [Related]
16. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
Bhongade BA; Gadad AK
J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
[TBL] [Abstract][Full Text] [Related]
17. Exploration of a binding mode of indole amide analogues as potent histone deacetylase inhibitors and 3D-QSAR analyses.
Guo Y; Xiao J; Guo Z; Chu F; Cheng Y; Wu S
Bioorg Med Chem; 2005 Sep; 13(18):5424-34. PubMed ID: 15963726
[TBL] [Abstract][Full Text] [Related]
18. Anticonvulsant and sodium channel-blocking properties of novel 10,11-dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives.
Benes J; Parada A; Figueiredo AA; Alves PC; Freitas AP; Learmonth DA; Cunha RA; Garrett J; Soares-da-Silva P
J Med Chem; 1999 Jul; 42(14):2582-7. PubMed ID: 10411478
[TBL] [Abstract][Full Text] [Related]
19. Diltiazem-like calcium entry blockers: a hypothesis of the receptor-binding site based on a comparative molecular field analysis model.
Corelli F; Manetti F; Tafi A; Campiani G; Nacci V; Botta M
J Med Chem; 1997 Jan; 40(1):125-31. PubMed ID: 9016337
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides.
Virsodia V; Pissurlenkar RR; Manvar D; Dholakia C; Adlakha P; Shah A; Coutinho EC
Eur J Med Chem; 2008 Oct; 43(10):2103-15. PubMed ID: 17950956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
